SecBot SecBot
SECBOTREPLAY Home › Report › PCRX

PCRX · Disclosure lawsuits disclosed

Pacira BioSciences, Inc. · SC TO-T/A filed Nov 12, 2026 at 16:16 ET

At the news

MIXEDIMPACT 7/10

SC TO-T/A filed Nov 12, 2026 at 16:16 ET

Viatris and its wholly owned subsidiary Peach Purchaser Sub Inc. filed Amendment No. 1 to their Schedule TO, updating the litigation section to disclose two stockholder lawsuits and fifteen demand letters challenging the adequacy of disclosures in the $36.50 per share cash tender offer for Pacira BioSciences. The Pacira defendants intend to vigorously defend the actions, and the offer terms remain unchanged.

  • Two stockholder complaints filed in New York Supreme Court alleging omitted/misrepresented information in Schedule 14D-9.
  • Fifteen demand letters (including two draft complaints) received by Pacira seeking additional disclosures.
  • Offer price remains $36.50 per share in cash, unchanged.
  • Pacira defendants intend to vigorously defend the actions.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access